Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Efficiency Gains Power Australian Clinical Labs Profit Higher as Revenue Stalls, Shares Jump

The full-year numbers, released alongside an investor webinar, told a story ofMarginrepair rather than growth. UnderlyingEarningsbefore interest and tax rose 1.7 per cent to $69.2 million, lifting the EBIT margin 20 basis points to 9.4 per cent. Underlying EBITDA edged up 0.2 per cent …

Sonal Goyal | 20 August 2026

Medibank FY26 Profit Rises 27% as Health Business Growth Supports Higher Dividend

Medibank Group (ASX:MPL) reported higher revenue and profit for FY26, with growth acrossHealth Insuranceand Medibank Health contributing to a 5.9% increase in group revenue to $9.12 billion. Underlying NPAT rose 2.9% to $636.8 million, while statutory NPAT attributable to shareholders increased 27.5% to $638.7 …

Sonal Goyal | 20 August 2026

CSL Limited (ASX:CSL) Share Price Rises After FY26 Results Reset Earnings Expectations

CSL Limited (ASX:CSL) shares closed at AUD 166.480 on 19 August 2026, increasing AUD 8.659 or 5.487% compared with the previous close of AUD 157.820. The stock traded between AUD 159.250 and AUD 166.480, with aVolumeof 3,879,713 shares.

Anjali Anand | 19 August 2026

Starpharma Ticks Up on Wednesday – Here’s Why

Starpharma's platform is dendrimer chemistry: precisely branched synthetic polymers that carry a drug payload and alter how and where it distributes in the body, branded DEP. Historically the technology was applied to reformulated chemotherapies and to consumer products including VivaGel BV and the VIRALEZE …

Sonal Goyal | 19 August 2026

Cogstate Ltd (ASX:CGS) Share Price Rises After FY26 Results Highlight Contract Growth

Cogstate Ltd (ASX:CGS) shares closed at AUD 2.930 on 19 August 2026, increasing AUD 0.200 or 7.326% compared with the previous close of AUD 2.730. The stock traded between AUD 2.690 and AUD 2.950, with aVolumeof 1,551,820 shares.

Anjali Anand | 19 August 2026

Cambium Bio (ASX:CMB) Share Price Holds Focus on Elate Ocular Clinical Development Pathway

Cambium Bio Limited (ASX:CMB) shares closed at AUD 0.410 on 19 August 2026, increasing AUD 0.010 or 2.500% compared with the previous close of AUD 0.400. The stock traded between AUD 0.380 and AUD 0.410, with aVolumeof 72,216 shares.

Anjali Anand | 19 August 2026

Sonic Healthcare Gains 2.8% in a Falling Market — But the Volume Says This Wasn't Results Day

Sonic Healthcare was quoted at $23.66 at 15:17 AEST on Wednesday 19 August 2026, up 2.76%, with 1.59 million shares traded. RelativeVolumewas 0.85 — below the stock's normal pace for that hour.

Sonal Goyal | 19 August 2026

Optiscan Imaging Limited (ASX:OIL) Adds 6.5% on Half Its Normal Volume

• Optiscan Imaging rose 6.45% to 16.5 cents by 15:17 AEST on Wednesday 19 August 2026, on turnover of 192,280 shares.

Aditi Sarkar | 19 August 2026

Proteomics International Laboratories (ASX:PIQ) Adds 3% on 29,000 Shares - But the Number That Matters Is 1.7

• No price-sensitive announcement was lodged with the ASX in the days before Wednesday's move.

Aditi Sarkar | 19 August 2026

Medical Developments International (ASX:MVP) Adds 5.1% on a Quarter of Normal Volume as Penthrox's Paediatric Green Light Meets Reporting Season

• Medical Developments International gained 5.10% to $0.515 by mid-afternoon on Wednesday 19 August 2026, on 54,750 shares.

Aditi Sarkar | 19 August 2026
Support

Hi! How can we help you today?

Loading…